Skip to main content
NCBI home page
ACS Omega logoLink to ACS Omega
. 2022 Jun 3;7(23):19879–19891. doi: 10.1021/acsomega.2c01667

Hybrid N-Acylcysteines as Dual-Acting Matrix Disruptive and Anti-Quorum Sensing Agents Fighting Pseudomonas aeruginosa Biofilms: Design, Synthesis, Molecular Docking Studies, and In Vitro Assays

Nader E Abo-Dya †,‡,*, Khalid A Agha §,*, Hisham A Abbas ∥, Mansour E Abu-Kull ⊥, Mohammed Issa Alahmdi #, Nermine A Osman ‡
PMCID: PMC9202021  PMID: 35721927

Abstract

graphic file with name ao2c01667_0014.jpg

Biofilms facilitate the pathogenesis of life-threatening Pseudomonas aeruginosa infections by coating mucosal surfaces or invasive devices and offer protection from antimicrobial therapy and the host immune response, thus increasing mortality rates and financial burden. Herein, new hybrid N-acylcysteines (NAC) incorporating selected acyl groups from organic acids and their derivatives, which are capable of quenching pathogen quorum sensing (QS) systems, were designed and their antibiofilm activity and anti-QS were evaluated. N-acylcysteines (4a–h) were synthesized and characterized by 1H NMR and 13C NMR, and their purity was confirmed by elemental analyses. N-(4-Hydroxy-3,5-dimethoxybenzoyl)-l-cysteine (4d) and N-(4-methoxybenzoyl)-l-cysteine (4h) showed a higher antibiofilm activity against PAO1 biofilms than the rest of the targets and the standard NAC. They showed 83 and 82% inhibition of biofilms at 5 mM and eradicated mature biofilms at 20 mM concentrations (NAC biofilm inhibition = 66% at 10 mM and minimum biofilm eradication concentration = 40 mM). This was confirmed via visualizing adherent biofilm cells on catheter pieces using scanning electron microscopy. In the same vein, both 4d and 4h showed the highest docking score with the QS signal receptor protein LasR (−7.8), which was much higher than that of NAC (−5) but less than the score of the natural agonist N-(3-oxododecanoyl)-l-homoserine (OdDHL) (−8.5). Target 4h (5 mM) decreased the expression of quorum sensing encoding genes in P. aeruginosa PAO1 strain by 53% for pslA, 47% for lasI and lasR, and 29% for filC, lowered PAO1 pyocyanin production by 76.43%, completely blocked the proteolytic activity of PAO1, and did not affect PAO1 cell viability. Targets 4d and 4h may find applications for the prevention and treatment of biofilm-mediated P. aeruginosa local infections of the skin, eye, and wounds. N-(4-Methoxybenzoyl)-l-cysteine 4h is a promising dual-acting matrix disruptive and anti-QS antibiofilm agent for further investigation and optimization.

1. Introduction

Microbial biofilms are formed when microbial cells are encased in a multicomponent extracellular matrix containing polysaccharides, proteins, and nucleic acids (Figure 1).1 Microorganisms often live in biofilms, which provide many advantages to their inhabitants: (i) they serve as a matrix for the exchange of metabolites, genetic units, and signaling molecules between cells and (ii) they protect their inhabitants from their natural predators and antimicrobial agents.2 Microbial biofilms are involved in the majority of infections that are related to mechanical ventilators, urinary catheters, and intravascular devices as well as chronic wound infections.3 Such biofilms complicate the treatment of microbial infections by improving microbial ability to evade the host immunity and resist the action of antimicrobial chemotherapeutics.4 The biofilm-mediated microbial resistance may be attributed to the hindered penetration of antimicrobial agents across the matrix of the biofilm and reduced oxygen and nutrients content, in addition to a slower metabolism. In addition, persister cells, high bacterial cell density, and activation of the general stress response are other factors that might contribute to the biofilm-mediated microbial resistance.4

Figure 1.

Figure 1

Open in a new tab

Composition of the EPS matrix: polysaccharides, enzymes, structural proteins, eDNA, and lipids. Reproduced with permission from ref (11). Copyright [2020/Frontiers] [Frontiers In Microbiology/Frontiers].

Pseudomonas aeruginosa is a highly life-threatening Gram-negative bacterium. It causes fatal nosocomial infections especially in hospitalized and immunocompromised patients.5 In 2017, WHO listed P. aeruginosa as one of the top priority pathogens representing an urgent threat that necessitates extensive research for the discovery of novel antibiotics.5 Biofilms facilitate the pathogenesis of P. aeruginosa infections by coating mucosal surfaces or invasive devices and offer protection from antimicrobial therapy and the host immune response, thus increasing mortality rates and financial burden.6 Cystic fibrosis patients are liable to a common biofilm-mediated chronic lung infection caused mainly by P. aeruginosa.7 In patients with burn wound infections, P. aeruginosa is a common etiological agent that causes morbidity.8P. aeruginosa biofilms were found on contact lenses as well as lens storage cases in wearers suffering from microbial keratitis.9 At comparable concentrations, NAC (N-acylcysteine) was able to treat chronic wounds before and after the formation of P. aeruginosa biofilms.10 It has been estimated that biofilms are associated with poor wound healing in millions of patients in the USA, resulting in economic consequences estimated at over $25 billion annually.5

NAC is a drug with mucolytic activity and has been reported as a matrix disruptive antibiofilm agent.11 NAC was reported as an antibiofilm agent capable of hindering the production of biofilms by different Gram-negative bacteria such as Escherichia coli, Klebsiella pneumonia, Enterobacter cloacae, Proteus spp., Pseudomonas mendocina, Acinetobacter baumannii, Prevotella intermedia, P. aeruginosa, and quinolone-resistant P. aeruginosa. NAC also showed antibiofilm activity toward Gram-positive bacteria including Enterococcus faecalis, Staphylococcus aureus, and Staphylococcus epidermidis as well as yeast, e.g., Candida albicans.(12) The antibiofilm activity of NAC is mediated by the prevention of the production of extracellular polysaccharide (EPS) matrixes and characterized by reduction of biofilm mass. NAC was also able to promote the disruption of mature biofilms.13,14

NAC has three functional groups: (i) sulfhydryl group (−SH), (ii) acetamido group (−NHCOCH3), and (iii) carboxylic acid (−COOH). The sulfhydryl group of NAC is very important for its mucolytic where its interaction with the disulfide bonds of mucoproteins breaks bronchial mucus into a more fluid form.15 The sulfhydryl group is important for the antimicrobial activity of NAC, which might be mediated by the competitive inhibition of bacterial utilization of cysteine or by the reaction of its sulfhydryl group with bacterial membranes.16 The conversion of the NAC sulfhydryl group to a thioether bond with poly(vinylsilsesquioxanes) and poly(methylvinylsiloxanes) exhibited a lower antibacterial activity. Nonetheless, both polymers retained NAC ability to eradicate mature biofilms.17,18

Despite the scarcity of medicinal chemistry research on NAC, the following SAR map of NAC was concluded based on previous literature reports (Figure 2). Martins-Green et al. compared the antibiofilm activity of NAC to analogous compounds, namely, N-acetylserine, glutathione, cysteine (Cys), and N-acetylcysteine amide (NACA). They concluded that the acetyl and carboxylic acid functional groups are very important for the antibiofilm activities where treatments by Cys and NACA did not disrupt biofilms visually or by CV staining.10 The replacement of (−SH) by a (−OH) group in N-acetylserine led to the retention of NAC antibiofilm activity.

Figure 2.

Figure 2

Open in a new tab

Importance of functional groups for the antibiofilm activity of NAC.

Organic acids and their derivatives were reported as agents capable of quenching pathogen quorum sensing (QS) machinery that is vital for biofilm formation.19 Vivanco and co-workers reported that salicylic acid and benzoic acid (Figure 3A,B) downregulated the virulence factors (pyocyanin production as well as elastase and proteases activities) of P. aeruginosa of20 Castillo-Juarez et al. demonstrated that 2-amino-6-chlorobenzoic acid (Figure 3C) and other anthranilic acid analogs interfered with pyocyanin and elastase production and enhanced the survival of infected mice via competitive inhibition of PqsA, a coenzyme A ligase, which represents the first step among other steps in the QS system of P. aeruginosa.(21) Syringic acid (Figure 3D) and other phenolic carboxylic acids were reported as QS inhibitors that can modulate N-acylhomoserine lactone (AHLs) activity and reduce EPS.22,23 4-Methoxybenzoic acid (Figure 3E) was able to (i) inhibit QS-mediated virulence factors including protease, elastase, and pyocyanin, (ii) reduce biofilm matrixes, and (iii) inhibit DNA transcripts of P. aeruginosa.(24) 4-Hydroxybenzoic acid is a phenolic acid found in many medicinal plants (Figure 3F) and was able to regulate Staphylococcus biofilm formation and viability25 and is a possible virulence attenuating agent that could suppress T3SS of Pst DC3000.26 4-Chlorobenzoic acid (Figure 3G) decreased the viability of Gram-positive and Gram-negative bacteria.27 In addition, ethyl-2-(4-chlorobenzoyl) acetate (Figure 3H) quenched quorum sensing machinery via competition with N-acyl homoserine lactones.28

Figure 3.

Figure 3

Open in a new tab

(A–H) Reported organic acids and a β-ketoester that interfere with quorum sensing.

Since NAC did not previously show quorum sensing inhibitory activity,29 we aimed at the replacement of its acetyl group with acyl groups from known inhibitors of bacterial quorum sensing such as organic acids and a β-ketoester (Figure 4) to produce dual-acting hybrid targets 4a–h. These hybrid N-acylcysteines 4a–h carry the structural features of NAC (−COOH, −SH, and −NHCO−) and aroyl groups from QS quenchers. Since N-acylbenzotriazoles can selectively acylate the amino and the thiol groups of cysteine,30 they were used in the preparation of N-acylcysteines 4a–h.

Figure 4.

Figure 4

Open in a new tab

Design of novel N-acylcysteines 4a–h.

The antibacterial activity (MICs) of targets 4a–h and the reference NAC were determined against P. aeruginosa ATCC 9027 (a biofilm-producing standard strain) using the broth microdilution method according to CLSI.31 Then, the ability of sub-MICs of the targets to inhibit P. aeruginosa biofilm formation and eradication was assessed. To investigate the effect of the new aroyl groups on anti-QS activity, targets 4a–h were docked in QS signal receptor protein LasR and their scores were compared with the natural ligand N-(3-oxododecanoyl)-L-homoserine. The target that showed the highest antibiofilm activity and the best binding mode (4h) was examined to explore its ability to inhibit P. aeruginosa virulence factors, namely, pyocyanin production as well as protease activity. Also, the effect of the most active target on the expression of genes encoding quorum sensing was assessed by quantitative RT-PCR.

2. Results and Discussion

2.1. Chemistry

2.1.1. Preparation of N-Acylcysteines 4a–h

N-Acylbenzotriazoles 3a–h intermediates were prepared in 76–90% yield via the reaction of carboxylic acids 2a–h with 1H-benzotriazole according to reported procedures.30,32,33N-Acylcysteines 4a–h (Scheme 1) were synthesized in 80–95% yields by reaction of L-cysteine with equimolar amounts of N-acylbenzotriazoles 3a–h and triethylamine in CH3CN-H2O (70%:30%) according to our previously reported method.31 The addition of one equivalent of TEA is essential to enhance an initial S-acylation of cysteine followed by N- to S- acyl transfer by a five-membered transition state, thus decreasing the possibility of diacylation. Interestingly, targets (4c and 4d) were prepared in excellent yields (93 and 91%, respectively) without the need for protection of the free amino group of 3c and 3d. Likewise, targets 4f and 4h were prepared in 91 and 87% yields, respectively, without the need for protection of the phenolic hydroxyl groups of 3f and 3h.

Scheme 1. Synthesis of N-Acylcysteines 4a–h.

Scheme 1

Open in a new tab

2.1.2. Molecular Docking Studies

AutoDock VINA implicated in the PyRx 0.8 tool was used to examine the molecular docking interaction of the synthesized N-acylcysteine 4a–h and QS receptor.34,35 The crystal structure (PDB code: 2UV0)36 of the QS signal receptor protein LasR with the agonist N-(3-oxododecanoyl)-l-homoserine (OdDHL) was used for this study. The docking reliability was supported by docking back the normal agonist OdDHL into the protein as a control. The docking scores are given in Table 1, where the produced docked complexes were investigated based on binding affinities values (kcal/mol) and the pattern of bonding interaction (electrostatic, hydrogen, and hydrophobic).

Table 1. Molecular Docking Scores of N-Acylcysteines 4a–h.
compound docking score (kcal/mol)
4a –6.9
4b –7.6
4c –7.1
4d –7.8
4e –6.7
4f 7.2
4g –7.4
4h –7.8
NAC –5
ref –8.5
Open in a new tab

Docking of OdDHL into the LasR receptor gave a pose that form the reported conventional hydrogen bonds along with other types of interactions with Thr75, Ser129, Tyr56, Tyr 93, Asp 73, and Trp60 in the X-ray structure; also, the long acyl chain extends into the cavity lined with hydrophobic residues, e.g., Leu-40, Tyr-47, Cys-79, Gly-126, Ala-127, Ala-70, Ala-127, Gly-38, and Thr115 Figure 5.

Figure 5.

Figure 5

Open in a new tab

3D representation of OdDHL in the LasR receptor.

Results presented in Table 1 show desirable binding energies with LasR and reveal how the substitution pattern on the benzoyl part is likely to control binding to LasR, which could explain their effects as quorum sensing inhibitors. N-Benzoylcysteine formed only one H-bond with Arg 61; it occupied the same core as the native ligand lactone ring and showed electrostatic interaction with Asp 73, Ser129, Thr75, Tyr 56, Leu 36, Tyr64, and Ala127 (Figure 6A). In contrast to the native ligand, the cysteine portion of the designed compounds extended in the hydrophobic cavity of LasR, forming two hydrogen bonds with Tyr 47 and Gly38, in addition to van der Waals interactions with Leu-40, Gly-126, Ile-52, Leu-125, and Leu-39. This new mode of interaction may prevent the correct formation of the hydrophobic core of LasR, which is mediated by the long acyl chain of the native inducer that controls the folding of the central β-sheet. This could result in an unstable protein and the observed QSI activity.36 Introducing amino or hydroxyl groups at the 4-position of the benzoyl ring led to a higher docking score (−7.6 and −7.2 kcal/mol, respectively) compared to the unsubstituted analog (−6.9 kcal/mol). Like N-benzoylcysteine, 4C, 4h (Figure 6B,C) formed one H-bond with Arg 61; also, π–anion and π–π stacked interactions with Asp 73 and Tyr 64 were observed in both compounds side by side with various van der Waals interactions. Amino group protons participate in an unfavorable donor–donor interaction with Thr 75 and Tyr 56, while the hydroxyl group forms a H-bond with Thr 75, Thr 115, and Ser 129.

Figure 6.

Figure 6

Open in a new tab

(A) 3D visualization of compound 4a in the LasR receptor, (B) 3D visualization of compound 4b in the LasR receptor, and (C) 3D visualization of compound 4f in the LasR receptor.

The methoxy group at the para position of the benzoyl part exhibited the best docking score of −7.8 kcal/mol. A comparative analysis of the pocket interactions revealed π–anion interactions between 4h and Asp73 while π–π stacked interaction with Tyr64. Additionally, π–alkyl interaction was elicited with Leu 36 and Ala 127 while a H-bond was observed with Arg 61 and Thr 115 (Figure 7A). In addition to these interactions, several van der Waals interactions collectively anchor compound 4h within a LasR binding pocket. Introducing chloride at the para position (Figure 7B) of compound 4g gives a score of −7.4 kcal/mol, which is near to that of the amino, hydroxyl, or even methoxy groups, thus reflecting the ability of the LasR pocket to accommodate these types of substitutions.

Figure 7.

Figure 7

Open in a new tab

(A) 3D visualization of compound 4c in the LasR receptor, (B) 3D visualization of compound 4g in the LasR receptor, and (C) 3D visualization of compound 4h in the LasR receptor.

Additional substitution with an amino group at the ortho position of compound 4g as in the case of compound 4c lowered the docking score to 7.1 kcal/mol and hindered the formation of a hydrogen bond with Tyr 47 observed with 4g while keeping other patterns of interactions like 4g (Figure 7c). This may reflect that substitution at the ortho position is not optimum for activity; this observation is strengthened by examining the interaction of compound 4e, which has only a hydroxyl group at the ortho position of the benzoyl part with LasR. In compound 4e, the docking score decreased to 6.7 kcal/mol and formed one H-bond with Arg 61 via its hydroxyl group, not with the carbonyl group of the benzoyl part like the rest of the designed compound, thus preventing anchoring the compound deeply in the LasR pocket occupied with the lactone ring part of the autoinducer compared to analog 4f with the hydroxyl group in the para position (Figure 8); thus, it cannot form H-bonds with Thr75, Thr115, and Ser129.

Figure 8.

Figure 8

Open in a new tab

Overlapping poses of 4e (yellow) and 4f (cyan) in the LasR receptor.

Target 4d has a higher docking score of −7.8 kcal/mol compared to 4f, indicating that the additional 3,5-dimethoxy groups maintained a better binding pattern with LasR (Figure 9).

Figure 9.

Figure 9

Open in a new tab

3D representation of intermolecular interactions exhibited by 3e.

2.2. Microbiology

2.2.1. Antibacterial Activity of N-Acetyl-l-cysteine and Synthetic Derivatives against P. aeruginosa (PAO1)

N-Acetyl-l-cysteine showed bacteriostatic activity against PAO1 at 40 mM. The synthetic derivatives showed variable bacteriostatic activities. Compounds 4d and 4h exhibited higher bacteriostatic activities than NAC. Their MIC values were lower (20 mM) than that of NAC (40 mM). The rest of the targets showed similar MIC values to NAC (40 mM) (Table 2).

Table 2. Antibacterial and Biofilm-Inhibiting Activities of NAC and Targets 4a–h.
compounds MIC (mM) 1/4 MIC (mM) OD590 (mean ± SD) % inhibition of biofilm formation
control (no drug) NA   0.452 ± 0.005 NA
NAC 40 10 0.152 ± 0.008 66.33%
4a 40 10 0.138 ± 0.008 69.51%
4b 40 10 0.266 ± 0.003 42.55%
4c 40 10 0.267 ± 0.010 41.14
4d 20 5 0.079 ± 0.004 82.62%
4e 40 10 0.169 ± 0.002 62.73%
4f 40 10 0.134 ± 0.005 70.33%
4g 40 10 0.095 ± 0.0005 79.08%
4h 20 5 0.0863 ± 0.0012 81.93%
Open in a new tab

2.2.2. Biofilm Inhibition Activities and SAR

Significant biofilm inhibition was achieved with NAC and all the targets 4a–h at 1/4 MIC values. The biofilm inhibiting activities were variable as compared to that caused by NAC. Replacement of the acetyl group of NAC with the benzoyl group of 4a led to 70% inhibition of biofilm formation, which is comparable to the antibiofilm activity of NAC (66% inhibition) at 10 mM. Substitution of the benzoyl group with 3,5-dimethoxy-4-hydroxy (4d) and 4-methoxy (4h) substituents resulted in the most potent compounds in the series wherein they inhibited biofilm formation by 82 and 83%, respectively, at 1/2 the concentration of 4b and NAC (5 mM). Interestingly, both 4d and 4h showed the highest docking score (−7.8) in the QS signal receptor protein LasR. While the substitution of the benzoyl group with the 4-hydroxy group gave equipotent compound 4f, the 4-chloro substitution in 4g showed a significantly higher percent inhibition of biofilm formation to 79% at 10 mM. On the other hand, 4-amino (4b), 2-amino-4-chloro (4c), and 2-hydroxy (4e) substitution lowered the percent inhibition of biofilm formation to 40, 41, and 62%, respectively, compared to 4a (70%) at 10 mM. These findings confirm that the acetyl group of NAC is not essential for its antibiofilm activity and that its replacement with an aryl group is a good strategy to develop new cysteine-containing antibiofilm compounds.

2.2.3. Biofilm Eradication by NAC and Selected Acylcysteine Derivatives

To investigate the disruption of biofilms of NAC in addition to compounds 4a, 4d, and 4f–h that showed similar or higher biofilm inhibition than NAC, their minimum biofilm eradication concentrations (MBECs) were determined (Table 3). Target 4d showed a two-fold higher activity than NAC (MBEC = 20 mM). The rest of the tested targets showed similar biofilm-eradicating activities to that of NAC.

Table 3. Biofilm-Eradicating Activities of NAC and Selected Derivatives.
compounds MBEC (mM)
NAC 40
4a 40
4d 20
4f 40
4g 40
4h 20
Open in a new tab

2.2.4. Scanning Electron Microscopy Images of Biofilms

To confirm the anti-biofilm activity of the tested agents, biofilms were formed at concentrations equal to the MBECs of these agents and they were examined under SEM. The images were compared to the control in which compact cells were attached to the matrix. In the case of the potential antibiofilm agents (4a, 4b, 4e–g, and 4j), the cells were very few or nearly absent (Figure 10). This was also the case for the biofilm matrix. These findings demonstrated the biofilm-eradicating capacity of the tested compounds.

Figure 10.

Figure 10

Open in a new tab

SEM visualization of biofilms in the presence and absence of MBECs of tested agents. The tested agents could inhibit biofilm formation as seen from the very few or nearly absent biofilm cells (×5000) as compared to the compact cells embedded in the biofilm matrix in the case of the control PAO1 biofilm.

4d and 4h showed the best biofilm inhibitory and the best biofilm-eradicating activities as well as the best docking score (−7.8) in QS signal receptor protein LasR. Since 4d showed unfavorable donor–donor interactions in its binding to LasR protein, 4h was chosen for further screening of anti-QS activity.

2.2.5. Target 4h Did Not Affect Cell Viability

Since 4h showed no effect on cell viability since 4h inhibited P. aeruginosa growth at 20 mM. The anti-virulence activities of 4h were evaluated at 1/4 MIC (5 mM). To ensure that 4h at sub-MIC does not affect cell growth, the optical densities of the suspensions with and without 4h were measured after allowing bacteria to grow overnight in LB broth. Also, the impact of 4h on bacterial viability was detected by viable counts after PAO1 treatment with sub-MIC of 4h. No significant differences between optical densities or bacterial viable counts were found between the 4h-treated bacteria and the untreated bacteria (Figure 11A).

Figure 11.

Figure 11

Open in a new tab

(A) Effect of 4h (5 mM) on PAO1 growth. (B) Effect of 4h (5 mM) against pyocyanin production in P. aeruginosa. (C) Effect of 4h against protease activity in P. aeruginosa. (D) Downregulation of QS encoding genes by RT-qPCR in the presence of 5 mM 4h compared to untreated PAO1.

2.2.6. Target 4h Reduced Pyocyanin Production

Pyocyanin (PCN) is a characteristic pigment that P. aeruginosa produces as a secondary metabolite. PCN facilitates biofilm formation via an eDNA-related mechanism.37 The ability of P. aeruginosa to produce its characteristic pyocyanin pigment was assessed both in the treated sample and the untreated one. Target 4h reduced the production of pyocyanin by 76.43% (Figure 11B).

2.2.7. Effect of Target 4h on PAO1 Protease Activity

To assess the inhibiting activity of 4h against protease activity in P. aeruginosa PAO1, the supernatants of treated and untreated cultures were added to the wells in skim milk agar plates and the clear zones due to protease activity were measured. Interestingly, 4h blocked entirely the protease activity of PAO1 at 5 mM (Figure 11C).

2.2.8. Target 4h Downregulated the Expression of Quorum Sensing Genes in P. aeruginosa

The impact of 4h on the expression of P. aeruginosa PAO1 virulence genes, namely, pslA, lasI lasR, and filC, was evaluated by employing qRT-PCR (Figure 11D). The 2–ΔΔCt method was applied to compare the expression of QS genes in both 4h-treated and untreated PAO1. Interestingly, the expression of all tested genes was significantly reduced in the presence of 5 mM 4h compared to the control PAO1 culture. The downregulation of the genes was 53% for pslA, 47% for each of lasI and lasR, and 29% for filC.

3. Conclusions

In conclusion, the hybridization of substituted benzoic acid and its derivatives with NAC improved its antibiofilm activity and enhanced its anti-QS activity as shown by molecular docking and in vitro studies. In the current work, N-(4-methoxybenzoyl)cysteine (4h) was the most promising target, showing the best docking score, binding mode, and % inhibition of PAO1 biofilm production and the capability of disrupting mature PAO1 biofilms at 20 mM. Target 4h is also able to downregulate quorum sensing encoding genes in P. aeruginosa by 53% pslA, 47% for lasI and lasR, and 29% for filC, reduce pyocyanin production, and completely block protease activity of PAO1. The results reported herein pave the way for future follow-up studies for the application of 4d and 4h in local biofilm-mediated P. aeuroginosa infections. In addition, more N-acylcysteines can be synthesized in search of optimized potency.

4. Experimental Section

4.1. Chemistry

4.1.1. General

Solvents and fine chemicals were obtained from commercial sources and utilized with no additional purification. A Fisher melting apparatus was used to determine melting points that are uncorrected. A JEOL a 500 MHz NMR spectrometer at the Faculty of Science, Mansoura University, was used to record the 1H NMR (500 MHz) and 13C NMR (125 MHz) spectra using DMSO-d6, D2O, and CDCl3 as solvents. On the other hand, a Bruker 400 MHz NMR spectrometer at the Faculty of Science, Zagazig University, was used to record the 1H NMR (400 MHz) and 13C NMR (100 MHz) spectra using DMSO-d6 as a solvent. Chemical shifts (δ) are given in ppm, and coupling constants (J) are reported in Hz. Elemental analyses were performed at the Regional Center for Mycology & Biotechnology, Al-Azhar University, on a Thermo Fisher Flash 2000 CHNS analyzer. The progress of the reactions was checked by (TLC), and short-length UV irradiation was used for visualization.

4.1.2. Synthesis of N-Acylcysteines 4a–h

N-acylbenzotriazoles were synthesized according to reported procedures. The NMR spectra of the reported N-acylbenzotriazoles and their melting points were consistent with their reported values.30,32,38

4.1.2.1. General Procedure for the Synthesis of N-Acylbenzotriazoles 3a–h

Benzotriazole (0.476 g, 4 mmol) was dissolved in CH2Cl2 (20 mL), and SOCl2 (1 mmol, 0.073 mL) was added. After stirring the mixture for 30 min at 25 °C, the corresponding carboxylic acid 2a–k (1 mmol) was added and stirring was continued for three more hours at 25 °C, and then CH2Cl2 (20 mL) was added to the reaction mixture. The methylene chloride layer was extracted with saturated Na2CO3 (3 × 10 mL), H2O (10 mL), and brine (10 mL) and dried over anhydrous sodium sulfate. Hexane (30 mL) was then added to CH2Cl2, and the precipitate formed was dried under vacuum to afford targets 3a–h.

(1H-Benzo[d][1,2,3]triazol-1-yl)(4-hydroxy-3,5-dimethoxyphenyl) Methanone (3d). White microcrystals, yield 0.227 g (76%); mp 109–111 °C. 1H NMR (500 MHz, DMSO-d6) δ 9.80 (s, 1H, OH), 8.28 (d, J = 8.0 Hz, 1H, Ar-H), 8.26 (d, J = 8.0 Hz, 1H, Ar-H), 7.81 (t, J = 7.8 Hz, 1H, Ar-H), 7.64 (t, J = 7.8 Hz, 1H, Ar-H), 7.52 (s, 2H, Ar-H), 3.85 (s, 6H, OCH3). 13C NMR (125 MHz, DMSO-d6) δ 165.4 (CO), 147.4 (=C-OCH3), 145.1 (C-N=N), 142.0 (=C-OH), 132.1 (-N (CO)-C=), 130.5 (Ar-C), 126.4 (Ar-C), 120.2 (Ar-C), 120.0 (Ar-C), 114.4 (Ar-C), 110.1 (Ar-C), 56.3 (OCH3). Anal. calcd for C15H13N3O4: C, 60.20; H, 4.38; N, 14.04. Found: C, 60.38; H, 4.44; N, 14.21%.

4.1.2.2. Procedure for the Synthesis of N-Acyl-l-Cysteines 4a–h

A solution of N-acyl/aroylbenzotriazole (1 mmol) in acetonitrile (7.5 mL) was added to a solution of l-cysteine (0.121 g, 1 mmol) in water (2.5 mL) and triethylamine (0.14 mL, 1 mmol). The reaction mixture was stirred for 1.5–2 h until the disappearance of N-acyl/aroylbenzotriazole spot from TLC. The solvent was evaporated under reduced pressure. Water (5 mL) was added to the residue and extracted with ethyl acetate (15 mL). The pH of the aqueous layer was adjusted at 5 using 2 N HCl and extracted with ethyl acetate (10 mL, 3×). The ethyl acetate layer was washed with 2 N HCl (2 mL, 3×), water (2 mL, 3×), and brine (2 mL, 3×). Evaporation of ethyl acetate afforded the target N-acylcysteine 4a–h.

N-Benzoyl-l-cysteine (4a). Gray microcrystals, yield 0.21 g (93%); mp 121–123 °C (Lit. 116–120 °C). 1H NMR (500 MHz, DMSO-d6) δ 8.78 (d, J = 7.5 Hz, 1H, NH), 7.84 (d, J = 7.0 Hz), 2H, OC-(ortho-Ar-H), 7.53 (t, J = 7.0 Hz, 1H, OC-(para-Ar-H)), 7.47–7.44 (m, 2H, OC-(meta-Ar-H)), 4.72–4.68 (m, 1H, -CH(COOH)), 3.29 (dd, J = 13.5, 4.5 Hz, 1H, HS-CH2), 3.12 (dd, J = 13.5, 10.0 Hz, 1H, HS-CH2), 1.17 (s, 1H, SH). 13C NMR (125 MHz, DMSO-d6) δ 172.7 (COOH), 166.3 (CONH), 151.9 (=C-NH2), 129.0 (OC-(ortho-Ar-C)), 120.4 (Ar-C), 112.5 (Ar-C), 51.9 (-CH(COOH)), 8.6 (-CH2SH). Anal. calcd for C10H12N2O3S: C, 49.99; H, 5.03; N, 11.66, S, 13.34. Found: C, 50.10; H, 5.09; N, 11.77; S, 13.42%.

N-(4-Aminobenzoyl)-l-cysteine (4b). Yellow microcrystals, yield 0.21 g (87%); mp 164–166 °C. 1H NMR (500 MHz, DMSO-d6) δ 8.25 (d, J = 7.5 Hz, 1H, NH), 7.57 (d, J = 8.5 Hz, 2H, OC-(ortho-Ar-H)), 6.53 (d, J = 8.5 Hz, 2H, OC-(meta-Ar-H)), 5.66 (s, 2H, NH2), 4.65–4.61 (m, 1H, (-CH(COOH))), 3.24 (dd, J = 14, 4.5 Hz, 1H, (-CH2SH)), 3.09 (dd, J = 14, 10.5 Hz, 1H,(-CH2SH)), 1.17 (s, 1H, SH). 13C NMR (125 MHz, DMSO-d6) δ 172.7 (COOH), 166.3 (CONH), 151.9 (=C-NH2), 129.0 (OC-(ortho-Ar-C)), 120.4 (Ar-C), 112.5 (Ar-C), 51.9 (-CH(COOH)), 8.6 (-CH2SH). Anal. calcd for C10H12N2O3S: C, 49.99; H, 5.03; N, 11.66, S, 13.34. Found: C, 50.10; H, 5.09; N, 11.77; S, 13.42%.

N-(2-Amino-4-chlorobenzoyl)-l-cysteine (4c). Buff microcrystals, yield 0.25 g (91%); mp 85–87 °C. 1H NMR (500 MHz, DMSO-d6) δ 7.91 (d, J = 7.0 Hz, 1H, NH), 7.50 (d, J = 10.0 Hz, 1H, OC-(ortho-Ar-H)), 6.72 (s, 1H, H2N-(ortho-Ar-H)), 6.64 (s, 2H, NH2), 6.50 (d, J = 10.0 Hz, 1H, Ar-H), 4.29 (s, br, 1H, -CH(COOH)), 3.43 (d, br, 1H, HS-CH2-), 3.08 (dd, J = 13.0, 6.5 Hz, 1H, HS-CH2-). 13C NMR (125 MHz, DMSO-d6) δ 172.7 (COOH), 167.7 (CO-NH-), 151.0 (=C-NH2), 136.3 (=C-Cl), 130.0 (Ar-C), 115.1 (Ar-C), 114.3 (Ar-C), 113.0 (Ar-C), 52.4 (-CH-COOH), 8.5 (HS-CH2-). Anal. calcd for C10H11ClN2O3S: C, 43.72; H, 4.04; N, 10.20, S, 11.67. Found: C, 43.85; H, 4.09; N, 10.32; S, 11.84%.

N-(4-Hydroxy-3,5-dimethoxybenzoyl)-l-cysteine (4d). Buff microcrystals, yield 0.26 g (86%); mp 76–78 °C. 1H NMR (500 MHz, DMSO-d6) δ 8.98 (s, 1H, OH), 8.62 (d, J = 7.5 Hz, 1H, NH), 7.19 (s, 2H, Ar-H), 4.73–4.68 (m, 1H, -CH(COOH)), 3.79 (s, 6H, m-OCH3), 3.29 (dd, J = 13.5, 4.5 Hz, 1H, HS-CH2), 3.11 (dd, J = 13.5, 10.0 Hz, 1H, HS-CH2), 1.17 (s, 1H, SH). 13C NMR (125 MHz, DMSO-d6) δ 172.4 (COOH), 166.1 (CONH), 147.4 (=C(OCH3)), 138.9 (=C(OH)), 123.4 (=CCO), 105.3 (Ar-C), 56.1 (OCH3), 52.0 (-CH(COOH)), 14.2 (HS-CH2). Anal. calcd for C12H15NO6S: C, 47.83; H, 5.02; N, 4.65, S, 10.64. Found: C, 47.94; H, 5.08; N, 4.69; S, 10.7%.

N-(2-Hydroxybenzoyl)-l-cysteine (4e). Oily, yield 0.22 g (91%). 1H NMR (500 MHz, DMSO-d6) δ 9.10 (s, 1H, NH), 7.89 (d, J = 7.5 Hz, 1H, Ar-H), 7.39 (d, J = 7.5 Hz, 1H, Ar-H), 6.94–6.87 (m, 2H, Ar-H), 4.74 (d br, 1H, CH(COOH)), 3.52 (dd, J = 13.5, 3.5 Hz, 1H, HS-CH2), 3.10 (dd, J = 13.5, 8.5 Hz, 1H, HS-CH2), 1.24 (s, 1H, SH). 13C NMR (125 MHz, DMSO-d6) δ 172.3 (COOH), 167.8 (HNCO), 159.2 (HO-C), 133.8 (Ar-C), 128.9 (Ar-C), 118.9 (Ar-C), 117.4 (Ar-C), 116.0 (Ar-C), 52.4 (HN-CH(COOH)), 12.5 (HS-CH2). Anal. calcd for C10H11NO4S: C, 49.78; H, 4.60; N, 5.81, S, 13.29. Found: C, 49.89; H, 4.65; N, 5.86; S, 13.37%.

N-(4-Hydroxybenzoyl)-l-cysteine (4f). Sticky, yield 0.21 g (87%). 1H NMR (500 MHz,D2O) δ 7.54 (d, J = 9.0 Hz, 2H), OC-(ortho-Ar-H), 6.76 (d, J = 9.0 Hz, 2H, OC-(meta-Ar-H)), 4.62 (dd, J = 8.5, 5.0 Hz, 1H, -CH(COOH)), 3.30 (dd, J = 14.0, 5.0 Hz, 1H,HS-CH2), 3.01 (dd, J = 14.0, 8.5 Hz, 1H, HS-CH2). 13C NMR (125 MHz, DMSO-d6/D2O) δ 178.5 (COOH), 170.8 (-NH-CO-), 160.8 (=C-OH), 134.3 (Ar-C), 131.0 (Ar-C), 116.9 (Ar-C), 56.4 (-CH(COOH)), 9.9(-CH2SH). Anal. calcd for C10H11NO4S: C, 49.78; H, 4.60; N, 5.81, S, 13.29. Found: C, 49.84; H, 4.67; N, 5.88; S, 13.35%.

N-(4-Chlorobenzoyl)-l-cysteine (4g). Sticky, yield 0.21 g (80%). 1H NMR (400 MHz, DMSO) δ 8.95 (s, 1H, NH), 7.96 (d, J = 8.0 Hz, 2H, CO(ortho-Ar-H)), 7.55 (d, J = 8.0 Hz, 2H, CO(meta-Ar-H)), 4.63 (br d, 1H, CH(COOH)), 3.32–3.14 (m, 1H, CH2SH), 3.05–2.68 (m, 1H, CH2SH), 1.20 (s, 1H, SH). 13C NMR (101 MHz, DMSO) δ 172.4 (COOH), 165.9 (=C-CO), 136.8(=C-Cl), 132.9(=C-CO), 129.8 (Ar-C), 128.8 (Ar-C), 56.1 (CH(COOH)), 8.9 (CH2SH). Anal. calcd for C10H10ClNO3S: C, 46.25; H, 3.88; N, 5.39; S, 12.34 Found: C, 46.35; H, 3.92; N, 5.44; S, 12.40%.

N-(4-Methoxybenzoyl)-l-cysteine (4h). White microcrystals, yield 0.24 g (94%); mp 63–65 °C. 1H NMR (500 MHz, DMSO-d6) δ 8.47 (d, J = 7.5 Hz, 1H, NH), 7.82 (d, J = 8.9 Hz, 2H, OC-(ortho-Ar-H)), 6.98 (d, J = 8.9 Hz, 2H, OC-(meta-Ar-H)), 4.68–4.64 (m, 1H, (-CH(COOH))), 3.79 (s, 3H, OCH3), 3.37 (dd, J = 13.6, 3.9 Hz, 1H, HS-CH2-), 3.07 (dd, J = 13.6, 10.1 Hz, 1H, HS-CH2-), 1.17 (s, 1H, SH). 13C NMR (125 MHz, DMSO-d6) δ 172.4 (COOH), 165.8 (CONH), 161.7 (=C(OCH3)), 129.2 (Ar-C), 126.1 (Ar-C), 113.5 (Ar-C), 55.4 (-CH(COOH)), 52.2 (OCH3), 8.5 (-CH2-SH). Anal. calcd for C11H13NO4S: C, 51.75; H, 5.13; N, 5.49, S, 12.56. Found: C, 51.87; H, 5.19; N, 5.54; S, 12.63%.

4.1.3. Computational Methodology

The crystal structure (PDB code: 2UV0) of the QS signal receptor protein LasR with the natural ligand N-(3-oxododecanoyl)-l-homoserine (OdDHL) was obtained from the protein data bank (PDB).36 In preparation for molecular docking, all nonstandard residues that include water were deleted followed by the addition of hydrogens. Marvin Sketch software was used to create the two-dimensional structures of the synthesized compounds. Three-dimensional structures of the targets 4a–h were built by optimization of the energy of their two-dimensional structures using Avogadro 1.2.0 software.39 The steepest descent algorithm was used for the optimization of molecular geometries of compounds in preparation for their molecular docking. AutoDock VINA (implicated in the PyRx 0.8 tool) was used to perform docking of compounds into LasR (the QS signal receptor protein).34,35 The included grid box coordinates of molecular docking were as follows: center: X = 23.032, Y = 16.29, and Z = 79.71 and dimensions: X = 16.45, Y = 17.62, and Z = 19.97. The molecular interactions of the docked complexes were viewed by Discovery Studio Visualizer.40

4.2. Antimicrobial and Antibiofilm Assays

4.2.1. Media and Chemicals

The media utilized in this study were tryptone soya broth and Mueller Hinton broth (Oxoid, Hampshire, UK). Dimethyl sulfoxide (DMSO) and N-acetyl-l-cysteine were purchased from (Sigma, St. Louis, USA). Other chemicals were of pharmaceutical grade.

4.2.2. Bacterial Strains

P. aeruginosa PAO1 strain was kindly supplied by the Department of Microbiology, Faculty of Pharmacy, Mansoura University.

4.2.3. Determination of Minimum Inhibitory Concentration (MIC)

The minimum inhibitory concentrations of NAC and the synthetic N-acylcysteines 4a–h were determined by applying the broth microdilution method. Serial (two-fold) dilutions of the tested compounds were prepared in Mueller-Hinton broth to produce dilutions of 80, 40, 20, 10, 5, 2.5, and 1.25 mM. Aliquots of 100 μL of the dilutions were added to the wells of a 96-well microtiter plate. Then, aliquots were added in volumes of 100 μL of PAO1 suspension prepared in Mueller-Hinton broth with an approximate cell density of 1 × 106 CFU/mL. The microtiter plate was incubated at 37 °C for 20 h, and the least concentration of each of the compounds that could inhibit the growth was considered the minimum inhibitory concentration of this compound.

4.2.4. Biofilm Inhibition Assay

The ability of the tested agents to inhibit biofilm formation was assessed by using the modified method of Stepanović et al.41 using 1/4 MIC of the tested agents. PAO1 was grown overnight in TSB and then diluted to produce a suspension with cell density approximating 106 CFU/mL. Then, aliquots of 5 mL of the prepared suspension were delivered into 15 mL Falcon tubes containing pieces of a urinary catheter (1 cm in length) in the presence and absence of 1/4 MIC of the tested agents. The tubes were incubated for 24 h at 37 °C. Then, the catheter pieces were removed and washed three times using sterile phosphate-buffered saline (PBS, pH 7.2) to remove any planktonic cells. Methanol (99%) was added for 20 min to fix the adherent cells. The catheter pieces were stained with crystal violet (0.5%) for 20 min. The non-adherent stain was removed by washing with distilled water. Then, glacial acetic acid (33%) was used to solubilize the dye. The absorbance of solubilized stain was measured at 590 nm with a Biotek Spectrofluorimeter (Biotek, USA), and the percentage of inhibition was calculated.

4.2.5. Determination of Minimum Biofilm Eradication Concentration (MBEC)

To determine the biofilm-eradicating activities of NAC and targets that showed similar or higher biofilm inhibition rates than NAC, the MBEC was determined by employing a modified method of Ceri et al.(42) PAO1 suspension was prepared in TSB (1 × 108 CFU/mL) and then diluted with TSB to a cell density of (1 × 106 CFU/mL). Biofilms were formed at first by adding aliquots of 100 μL to the wells of microtiter plates that were incubated at 37 °C for 24 h. After removal of non-attached cells and washing the wells with sterile PBS, aliquots of 100 μL of the tested agents’ dilutions were added to the wells of the plates that were incubated at 37 °C for 24 h. The contents were removed, and the wells were washed before re-suspending the attached cells by adding aliquots of 100 μL of PBS and scraping the sides of the wells with a pipette tip. To calculate MBEC, 10 μL from each of the wells was plated on tryptone soy agar (TSA) plates that were incubated at 37 °C for 24 h. MBECs were the lowest concentrations that inhibited growth on TSA.

4.2.6. Scanning Electron Microscopy of Catheter Pieces

To visualize the eradicating effects of the tested agents 4a, 4d, 4f, 4g, and 4h and NAC on biofilm formation by P. aeruginosa PAO1 strain, the adherent biofilm cells formed on catheter pieces in the same way as in the biofilm inhibition assay but in the presence and absence of MBECs of the tested agents. The catheter pieces were left overnight to dry, and then the biofilms were fixed using 2.5% glutaraldehyde in PBS (0.2 M, pH 7.4). Then, they were prepared for examination using a scanning electron microscope as previously described.43

4.2.7. Determination of the Effect of Sub-MIC of 4h on the Growth of Bacteria

The potential effect of 1/4 MIC (5 mM) of 4h on PAO1 growth was detected using Nalca et al. method.44 First, PAO1 was grown overnight and this culture was used to inoculate LB broth containing 4h and control LB broth. The optical densities of both cultures were measured after overnight incubation at 37 °C using a Biotek Spectrofluorimeter (Biotek, USA) at 600 nm. The sub-inhibitory concentration of 4h (5 mM) was used to assess its potential anti-virulence as well as its quorum sensing inhibiting activities against P. aeruginosa.

4.2.8. Pyocyanin Assay

The production of pyocyanin (bluish-green pigment) by 4h (5 mM)-treated PAO1 and the control PAO1 strain cultures was assessed using the reported procedures by Das and Manefield.45 A PAO1 culture in LB broth was prepared with an optical density of 0.4 at 600 nm. LB broth tubes (1 mL) with and without 4h were inoculated with 10 μL aliquots of PAO1 suspension, and the tubes were incubated for 48 h at 37 °C. The supernatants were separated by centrifugation at 10, 000 rpm for 10 min. Pyocyanin was measured in the supernatants spectrophotometrically at 691 nm. The test was made in triplicate.

4.2.9. Protease Assay

To determine the effect of 4h (5 mM) on the protease activity of PAO1 strain, the skim milk agar method was employed.46 The supernatants of 4h-treated PAO1 culture and control culture were obtained by centrifugation. Aliquots of 100 μL were added to wells in skim milk agar plates that were incubated overnight at 37 °C. The clear zones due to protease activity were measured, and the test was made in triplicate.

4.2.10. Total RNA Extraction for qRT-PCR and Quantitative RT-PCR of QS Genes

The ability of 4h (5 mM) to downregulate quorum sensing genes was assessed by RNA extraction of 4h-treated and untreated cultures of PAO1 using a Gene Jet RNA Purification Kit (Thermo Scientific, USA) following the instructions of the manufacturer. Control and treated PAO1 cultures were prepared and centrifuged at 12000g for 2 min to collect the pellets. The pellets were then resuspended in Tris-EDTA buffer containing lysozyme (100 μL) and incubated at 25 °C for 5 min. Lysis buffer containing B-mercaptoethanol was added and mixed well. RNA was eluted after purification with 100 μL of nuclease-free water and was stored at −70 °C until use.

qRT-PCR was used to assess the relative expression levels of QS genes in PAO1 strain treated and untreated with 4h using the primers listed in Table 4.47−49 The housekeeping gene rpoD was used to normalize the relative expression level of tested genes. A StepOne Real-Time PCR system (Applied Biosystems, USA) was used, employing a SensiFAST SYBR Hi-ROX One-Step Kit protocol (Bioline, UK). Agarose gel electrophoresis and melting curve analysis of products were used to confirm the specific PCR amplification, and the comparative threshold cycle (ΔΔCt) method50 was used to calculate the relative gene expression.51

Table 4. List of Primers Used in RT-PCRa.
gene name primer sequence
ropD (F) 5′-CGAACTGCTTGCCGACTT-3′
ropD (R) 5′-GCGAGAGCCTCAAGGATAC-3′
lasI (F) 5′-CGCACATCTGGGAACTCA-3′
lasI (R) 5′-CGGCACGGATCATCATCT-3′
lasR (F) 5′-CTGTGGATGCTCAAGGACTAC-3′
lasR (R) 5′-AACTGGTCTTGCCGATGG-3′
fliC (F) 5′-GTCAACACGAACATTGCTTCCC-3′
fliC (R) 5′-TTGCTGCCGACCTGGTAAGAAC-3′
PslA (F) 5′-AAGATCAAGAAACGCGTGGAAT-3′
PslA (R) 5′-TGTAGAGGTCGAACCACACCG-3′
Open in a new tab
a

F = Forward, R = Reverse.

4.3. Statistical Analysis

One-way ANOVA tests, Student t-tests, and Graph Pad Prism 5 were used to study the significance of the inhibitory activities of 4h against the virulence factors of P. aeruginosa PAO1 strain. P values < 0.05 were considered statistically significant.

Acknowledgments

The authors would like to thank the Deanship of Scientific Research at the University of Tabuk for funding this work.

Supporting Information Available

The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsomega.2c01667.

  • Scans of 1H NMR and 13C NMR spectra and 2D binding modes of 4a–h with QS signal receptor protein LasR (PDF)

This research was funded by the University of Tabuk (grant number S-1438-0051).

The authors declare no competing financial interest.

Supplementary Material

ao2c01667_si_001.pdf (985.6KB, pdf)

References

  1. Limoli D. H.; Jones C. J.; Wozniak D. J. Bacterial Extracellular Polysaccharides in Biofilm Formation and Function. Microbiol. Spectrum 2015, 3, 1–19. 10.1128/microbiolspec.MB-0011-2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Flemming H.; Wuertz S. Bacteria and archaea on Earth and their abundance in biofilms. Nat. Rev. Microbiol. 2019, 17, 247–260. 10.1038/s41579-019-0158-9. [DOI] [PubMed] [Google Scholar]
  3. Costerton J. W.; Stewart P. S.; Greenberg E. P. Bacterial Biofilms: A Common Cause of Persistent Infections. Science 1999, 284, 1318–1322. 10.1126/science.284.5418.1318. [DOI] [PubMed] [Google Scholar]
  4. Sharma D.; Misba L.; Khan A. U. Antibiotics versus biofilm: an emerging battleground in microbial communities. Antimicrob. Resist. Infect. Control. 2019, 8, 76–86. 10.1186/s13756-019-0533-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Thi M. T.; Wibowo D.; Rehm B. H. A. Pseudomonas aeruginosa Biofilms. Int. J. Mol. Sci. 2020, 21, 8671. 10.3390/ijms21228671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Maurice N. M.; Bedi B.; Sadikot R. T. Pseudomonas aeruginosa Biofilms: Host Response and Clinical Implications in Lung Infections. Am. J. Respir. Cell Mol. Biol. 2018, 58, 428–439. 10.1165/rcmb.2017-0321TR. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Faure E.; Kwong K.; Nguyen D. Pseudomonas aeruginosa in Chronic Lung Infections: How to Adapt Within the Host?. Front. Immunol. 2018, 9, 2416. 10.3389/fimmu.2018.02416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. D’Arpa P.; Karna S. L. R.; Chen T.; Leung K. P. Pseudomonas aeruginosa transcriptome adaptations from colonization to biofilm infection of skin wounds. Sci. Rep. 2021, 11, 1–13. 10.1038/s41598-021-00073-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. McLaughlin-Borlace; Stapleton; Matheson; Dart Bacterial biofilm on contact lenses and lens storage cases in wearers with microbial keratitis. J. Appl. Microbiol. 1998, 84, 827–838. 10.1046/j.1365-2672.1998.00418.x. [DOI] [PubMed] [Google Scholar]
  10. Li X.; Kim J.; Wu J.; Ahamed A. I.; Wang Y.; Martins-Green M. N-Acetylcysteine and Mechanisms Involved in Resolution of Chronic Wound Biofilm. J. Diabetes Res. 2020, 2020, 9589507. 10.1155/2020/9589507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Pinto R. M.; Soares F. A.; Reis S.; Nunes C.; Van Dijck P. Innovative Strategies Toward the Disassembly of the EPS Matrix in Bacterial Biofilms. Front. Microbiol. 2020, 11, 952. 10.3389/fmicb.2020.00952. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Blasi F.; Page C.; Rossolini G. M.; Pallecchi L.; Matera M. G.; Rogliani P.; Cazzola M. The effect of N-acetylcysteine on biofilms: Implications for the treatment of respiratory tract infections. Respir. Med. 2016, 117, 190–197. 10.1016/j.rmed.2016.06.015. [DOI] [PubMed] [Google Scholar]
  13. Kundukad B.; Schussman M.; Yang K.; Seviour T.; Yang L.; Rice S. A.; Kjelleberg S.; Doyle P. S. Mechanistic action of weak acid drugs on biofilms. Sci. Rep. 2017, 7, 4783–4783. 10.1038/s41598-017-05178-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Romanò C. L.; Toscano M.; Romanò D.; Drago L. Antibiofilm agents and implant-related infections in orthopaedics: where are we?. Aust. J. Chem. 2013, 25, 67–80. 10.1179/1973947812Y.0000000045. [DOI] [PubMed] [Google Scholar]
  15. Sadowska A. M. N-Acetylcysteine mucolysis in the management of chronic obstructive pulmonary disease. Ther. Adv. Respir. Dis. 2012, 6, 127–135. 10.1177/1753465812437563. [DOI] [PubMed] [Google Scholar]
  16. Aslam S.; Darouiche R. O. Role of Antibiofilm-Antimicrobial Agents in Controlling Device-Related Infections. Int. J. Artif. Organs 2011, 34, 752–758. 10.5301/ijao.5000024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Yang S.; Tran C.; Whiteley G. S.; Glasbey T.; Kriel F. H.; McKenzie D. R.; Manos J.; Das T. Covalent Immobilization of N-Acetylcysteine on a Polyvinyl Chloride Substrate Prevents Bacterial Adhesion and Biofilm Formation. Langmuir 2020, 36, 13023–13033. 10.1021/acs.langmuir.0c02414. [DOI] [PubMed] [Google Scholar]
  18. Kregiel D.; Rygala A.; Kolesinska B.; Nowacka M.; Herc A. S.; Kowalewska A. Antimicrobial and Antibiofilm N-acetyl-L-cysteine Grafted Siloxane Polymers with Potential for Use in Water Systems. Int. J. Mol. Sci. 2019, 20, 2011. 10.3390/ijms20082011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Amrutha B.; Sundar K.; Shetty P. H. Effect of organic acids on biofilm formation and quorum signaling of pathogens from fresh fruits and vegetables. Microb. Pathog. 2017, 111, 156–162. 10.1016/j.micpath.2017.08.042. [DOI] [PubMed] [Google Scholar]
  20. Prithiviraj B.; Bais H. P.; Weir T.; Suresh B.; Najarro E. H.; Dayakar B. V.; Schweizer H. P.; Vivanco J. M. Down Regulation of Virulence Factors of Pseudomonas aeruginosa by Salicylic Acid Attenuates Its Virulence on Arabidopsis thaliana and Caenorhabditis elegans. Infect. Immun. 2005, 5319. 10.1128/IAI.73.9.5319-5328.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Castillo-Juarez I.; Lopez-Jacome L. E.; Soberon-Chavez G.; Tomas M.; Lee J.; Castaneda-Tamez P.; Hernandez-Barragan I. A.; Cruz-Muniz M. Y.; Maeda T.; Wood T. K.; Garcia-Contreras R. Exploiting Quorum Sensing Inhibition for the Control of Pseudomonas aeruginosa and Acinetobacter baumannii Biofilms. Curr Top Med Chem 2017, 17, 15–1927. 10.2174/1568026617666170105144104. [DOI] [PubMed] [Google Scholar]
  22. Borges A.; Serra S.; Abreu A. C.; Saavedra M. J.; Salgado A.; Simões M. Evaluation of the effects of selected phytochemicals on quorum sensing inhibition and in vitro cytotoxicity. Biofouling 2014, 30, 183–195. 10.1080/08927014.2013.852542. [DOI] [PubMed] [Google Scholar]
  23. Minich A.; Levarski Z.; Mikulášová M.; Straka M.; Liptáková A.; Stuchlík S. Complex Analysis of Vanillin and Syringic Acid as Natural Antimicrobial Agents against Staphylococcus epidermidis Biofilms. Int. J. Mol. Sci. 2022, 23, 1816. 10.3390/ijms23031816. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Danaraj J.; Mariasingarayan Y.; Ayyappan S.; Karuppiah V. Seagrass Halodule pinifolia active constituent 4-methoxybenzioic acid (4-MBA) inhibits quorum sensing mediated virulence production of Pseudomonas aeruginosa. Microb. Pathog. 2020, 147, 104392. 10.1016/j.micpath.2020.104392. [DOI] [PubMed] [Google Scholar]
  25. Jagani S.; Chelikani R.; Kim D. Effects of phenol and natural phenolic compounds on biofilm formation by Pseudomonas aeruginosa. Biofouling 2009, 25, 321–324. 10.1080/08927010802660854. [DOI] [PubMed] [Google Scholar]
  26. Kang J. E.; Jeon B. J.; Park M. Y.; Kim B. S. Inhibitory Activity of Sedum middendorffianum-Derived 4-Hydroxybenzoic Acid and Vanillic Acid on the Type III Secretion System of Pseudomonas syringae pv. tomato DC3000. Plant Pathol. J. 2020, 36, 608–617. 10.5423/PPJ.OA.08.2020.0162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Park S.; Ko Y.; Kim C. Toxic Effects of Catechol and 4-Chlorobenzoate Stresses on Bacterial Cells. J. Microbiol. 2001, 39, 206–212. [Google Scholar]
  28. Forschner-Dancause S.; Poulin E.; Meschwitz S. Quorum Sensing Inhibition and Structure–Activity Relationships of β-Keto Esters. Molecules 2016, 21, 971. 10.3390/molecules21080971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Fulghesu L.; Giallorenzo C.; Savoia D. Evaluation of Different Compounds as Quorum Sensing Inhibitors in Pseudomonas aeruginosa. Aust. J. Chem. 2007, 19, 388–390. 10.1179/joc.2007.19.4.388. [DOI] [PubMed] [Google Scholar]
  30. Katritzky A. R.; Tala S. R.; Abo-Dya N. E.; Gyanda K.; El-Gendy B. E. M.; Abdel-Samii Z. K.; Steel P. J. Selective Synthesis and Structural Elucidation of S-Acyl- and N-Acylcysteines. J. Org. Chem. 2009, 74, 7165–7167. 10.1021/jo900853s. [DOI] [PubMed] [Google Scholar]
  31. https://clsi.org/standards/products/microbiology/documents/m07/
  32. Agha K. A.; Abo-Dya N. E.; Ibrahim T. S.; Abdel-Aal E. H. Efficient synthesis of N-acylbenzotriazoles using tosyl chloride: en route to suberoylanilide hydroxamic acid (SAHA). ARKIVOC 2016, 3, 161–170. 10.3998/ark.5550190.p009.459. [DOI] [Google Scholar]
  33. Kaniskan N.; Kokten S.; Celik I. A new protocol for the synthesis of primary, secondary and tertiary anthranilamides utilizing N-(2-aminoarylacyl)benzotriazoles. ARKIVOC 2013, 198–213. 10.3998/ark.5550190.0013.818. [DOI] [Google Scholar]
  34. Dallakyan S.; Olson A. J.. Small-Molecule Library Screening by Docking with PyRx. In Chemical Biology: Methods and Protocols; Hempel J. E.; Williams C. H.; Hong C. C., Eds.; Springer New York: New York, NY, 2015; pp. 243–250. [DOI] [PubMed] [Google Scholar]
  35. Trott O.; Olson A. J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 2010, 31, 455–461. 10.1002/jcc.21334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Bottomley M. J.; Muraglia E.; Bazzo R.; Carfì A. Molecular Insights into Quorum Sensing in the Human Pathogen Pseudomonas aeruginosa from the Structure of the Virulence Regulator LasR Bound to Its Autoinducer*. J. Biol. Chem. 2007, 282, 13592–13600. 10.1074/jbc.M700556200. [DOI] [PubMed] [Google Scholar]
  37. Das T.; Kutty S. K.; Kumar N.; Manefield M. Pyocyanin Facilitates Extracellular DNA Binding to Pseudomonas aeruginosa Influencing Cell Surface Properties and Aggregation. PLoS One 2013, 8, e58299 10.1371/journal.pone.0058299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Agha K. A.; Abo-Dya N. E.; Ibrahim T. S.; Abdel-Aal E. H.; Abdel-Samii Z. K. N-Acylbenzotriazole: convenient approach for protecting group-free monoacylation of symmetric diamines. Monatsh. Chem. 2020, 151, 589–598. 10.1007/s00706-020-02579-5. [DOI] [Google Scholar]
  39. Hanwell M. D.; Curtis D. E.; Lonie D. C.; Vandermeersch T.; Zurek E.; Hutchison G. R. Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. Aust. J. Chem. 2012, 4, 17. 10.1186/1758-2946-4-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. https://www.3ds.com/products-services/biovia/products/molecular-modeling-simulation/biovia-discovery-studio/visualization/
  41. Stepanović S.; Vuković D.; Dakić I.; Savić B.; Švabić-Vlahović M. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J. Microbiol. Methods 2000, 40, 175–179. 10.1016/S0167-7012(00)00122-6. [DOI] [PubMed] [Google Scholar]
  42. Ceri H.; Olson M. E.; Stremick C.; Read R. R.; Morck D.; Buret A. The Calgary Biofilm Device: New Technology for Rapid Determination of Antibiotic Susceptibilities of Bacterial Biofilms. J. Clin. Microbiol. 1999, 6, 1771–1776. 10.1128/JCM.37.6.1771-1776.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Shehadat S. A.; Gorduysus M. O.; Hamid S. S. A.; Abdullah N. A.; Samsudin A. R.; Ahmad A. Optimization of scanning electron microscope technique for amniotic membrane investigation: A preliminary study. Eur. J. Dent. 2019, 12, 574–578. 10.4103/ejd.ejd_401_17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Nalca Y.; Jänsch L.; Bredenbruch F.; Geffers R.; Buer J.; Häussler S. Quorum-Sensing Antagonistic Activities of Azithromycin in Pseudomonas aeruginosa PAO1: a Global Approach. Antimicrob. Agents Chemother. 2006, 50, 1680–1688. 10.1128/AAC.50.5.1680-1688.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Das T.; Manefield M. Pyocyanin Promotes Extracellular DNA Release in Pseudomonas aeruginosa. PLoS One 2012, 7, e46718 10.1371/journal.pone.0046718. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Vijayaraghavan P.; Vincent S. A simple method for the detection of protease activity on agar plates using bomochresolgreen dye. J. Biochem. Technol. 2013, 4, 628–630. [Google Scholar]
  47. Krishnan T.; Yin W.; Chan K. Inhibition of Quorum Sensing-Controlled Virulence Factor Production in Pseudomonas aeruginosa PAO1 by Ayurveda Spice Clove (Syzygium Aromaticum) Bud Extract. Sensors 2012, 12, 4016–4030. 10.3390/s120404016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. El-Mowafy S. A.; Abd El G.; Khaled H.; El-Messery S. M.; Shaaban M. I. Aspirin is an efficient inhibitor of quorum sensing, virulence and toxins in Pseudomonas aeruginosa. Microb. Pathog. 2014, 74, 25–32. 10.1016/j.micpath.2014.07.008. [DOI] [PubMed] [Google Scholar]
  49. Colvin K. M.; Irie Y.; Tart C. S.; Urbano R.; Whitney J. C.; Ryder C.; Howell P. L.; Wozniak D. J.; Parsek M. R. The Pel and Psl polysaccharides provide Pseudomonas aeruginosa structural redundancy within the biofilm matrix. Environ. Microbiol. 2012, 14, 1913–1928. 10.1111/j.1462-2920.2011.02657.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Casciaro B.; Lin Q.; Afonin S.; Loffredo M. R.; Turris V. d.; Middel V.; Ulrich A. S.; Di Y. P.; Mangoni M. L. Inhibition of Pseudomonas aeruginosa biofilm formation and expression of virulence genes by selective epimerization in the peptide Esculentin-1a(1-21)NH2. FEBS J. 2019, 286, 3874–3891. 10.1111/febs.14940. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Livak K. J.; Schmittgen T. D. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method. Methods 2001, 25, 402–408. 10.1006/meth.2001.1262. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

ao2c01667_si_001.pdf (985.6KB, pdf)

Articles from ACS Omega are provided here courtesy of American Chemical Society

RESOURCES